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Abstract
Androgenetic alopecia, known in men as male pattern baldness (MPB), is a very conspicu-
ous condition that is particularly frequent among European men and thus contributes
markedly to variation in physical appearance traits amongst Europeans. Recent studies
have revealed multiple genes and polymorphisms to be associated with susceptibility to
MPB. In this study, 50 candidate SNPs for androgenetic alopecia were analyzed in order to
verify their potential to predict MPB. Significant associations were confirmed for 29 SNPs
from chromosomes X, 1, 5, 7, 18 and 20. A simple 5-SNP prediction model and an extended
20-SNP model were developed based on a discovery panel of 305 males from various Eu-
ropean populations fitting one of two distinct phenotype categories. The first category con-
sisted of men below 50 years of age with significant baldness and the second; men aged 50
years or older lacking baldness. The simple model comprised the five best predictors:
rs5919324 near AR, rs1998076 in the 20p11 region, rs929626 in EBF1, rs12565727 in
TARDBP and rs756853 in HDAC9. The extended prediction model added 15 SNPs from
five genomic regions that improved overall prevalence-adjusted predictive accuracy mea-
sured by area under the receiver characteristic operating curve (AUC). Both models were
evaluated for predictive accuracy using a test set of 300 males reflecting the general
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European population. Applying a 65% probability threshold, high prediction sensitivity of
87.1% but low specificity of 42.4% was obtained in men aged <50 years. In men aged50,
prediction sensitivity was slightly lower at 67.7% while specificity reached 90%. Overall, the
AUC=0.761 calculated for men at or above 50 years of age indicates these SNPs offer con-
siderable potential for the application of genetic tests to predict MPB patterns, adding a
highly informative predictive system to the emerging field of forensic analysis of externally
visible characteristics.
Introduction
Androgenetic alopecia (AGA), often termed male pattern baldness (MPB), is a widespread
type of gradual hair loss from the scalp that is particularly frequent among European males.
The etiology of male pattern baldness has been widely researched and although it is still not
fully understood, major factors behind this condition have been identified to comprise genetic
predisposition and hormone dependency [1]. It has been estimated that approximately 80% of
the variance of AGA-related hair loss can be explained by genetic factors [2,3]. Multiple studies
including several recent genome-wide association analyses have disclosed a large number of
single nucleotide polymorphisms (SNPs) associated with AGA susceptibility and provided
strong evidence that the region on chromosome X, which includes the two neighboring genes
of androgen receptor (AR) and ectodysplasin A2 receptor (EDA2R), is involved in MPB [4–
12]. Although involvement of the Xq12 region in AGA appears to be undisputed, various re-
ports are discordant in terms of the number of loci and effect size associated with particular
variants located near the AR/EDA2R genes. Fine mapping of this region by Brockschmidt et al.
in 2010 indicated locus rs12558842, located upstream of AR and EDA2R, has the strongest as-
sociation with AGA and suggested there are likely to be 1–2 causative variants in this region
regulating expression of AR and/or EDA2R genes [10]. The complexity of genetic determina-
tion of MPB was further highlighted by a study that reported three SNPs from the AR/EDA2R
region to be monomorphic among Asians, concluding that this locus is unlikely to play any
role in AGA in Asia [13]. A region located at 20p11 represents the second MPB susceptibility
locus, discovered independently by two genome wide association studies (GWAS) and further
confirmed in both Europeans and Asians. Effect size attributed to this locus was found to be
lower than AR/EDA2R indicating approximately two-fold increased risk of AGA in Europeans
and Asians [9,13,14]. GWAS followed by fine-mapping analysis has confirmed the significance
of both chromosome X and chromosome 20 regions [10], whereas a further study by the same
group in 2011 identified HDAC9 in 7p21.1 to be a novel susceptibility locus for AGA [15]. The
large meta-analysis confirmed the association of Xq12, 20p11, and HDAC9 while discovering
five additional loci associated with early onset baldness in Europeans. These novel AGA risk
loci comprised: region 17q21.31; TARDBP (chr1); HDAC4 (chr2); AUTS2 (chr7); and SETBP1
(chr18) [12]. In the follow-up study, Heilmann et al. (2013) investigated 12 genomic regions
for which Li et al. (2012) found suggestive associations, however these additional regions did
not achieve genome-wide significance [16]. Nevertheless, Heilmann’s study revealed associa-
tion with MPB for four additional regions: 2q35 (WNT10A); chr3q25 (SUCNR1); chr5q33.3
(EBF1); and chr12p12.1 (SSPN), extending the list of known AGA susceptibility loci to 12 po-
tential predictors for this condition.
Genetic association is often a first step to discover the biological function of genetic variants
[17]. The identified DNA variants may also find direct application in prediction modeling,
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which in medical genetics can be used to estimate the risk to develop a disease. In forensic
DNA analysis such markers can be applied to predict externally visible characteristics (EVCs)
of an unknown person, whose DNA is available for analysis [18,19]. Male hair distribution is
one of the most obvious externally visible traits and thus the prediction of MPB will be useful
in forensic investigations. Prediction modeling performed on other EVCs has shown that the
current known DNAmarkers associated with iris pigmentation are sufficient to predict blue
and brown eye colour [20], while hair colour [21] and chronological age [22–24] have recently
been added as informative tests. Other appearance traits like stature or facial morphology are
much more complex and need further extensive studies before they can be added to predictive
frameworks in forensic analysis [25,26]. In the present study, we investigated the loci that have
been associated with androgenetic alopecia with the aim to evaluate their significance for MPB
and assess their potential as predictors for early onset baldness in European males.
Materials and Methods
Ethics statement
Written informed consent was obtained from all sample donors. The study was approved by
each regional bioethics committee: the Commission on Bioethics of the Regional Board of
Medical Doctors in Krakow (48 KBL/OIL/2008); the Danish committee system on biomedical
research ethics (H-3-2012-023); the KCL BDM Research Ethics Subcommittee (BDM/13/14-
111); the USC ethics committee of clinical investigation in Galicia, Spain (CEIC: 2009/246) and
followed approved internal procedures in the Netherlands Forensic Institute in The Hague.
Sample collection
A total of 605 samples were collected from healthy male donors from the following European
populations: 448 males from Poland, 49 from the Netherlands, 36 from the United Kingdom,
27 from Denmark, 20 from Italy, 13 from Germany and 12 from Spain. Phenotype classifica-
tion involved direct inspection of subjects by a dermatology specialist or evaluation of multiple
high quality photographs per subject. The degree of baldness was assessed on a seven-point
scale according to the Norwood-Hamilton classification system [1,27]. The phenotypic de-
scriptions of Norwood-Hamilton baldness categories are given in S1 Table. Collected samples
were further divided into four phenotype categories distinguishing two extremes according to
age/baldness severity: phenotype category 1, men below 50 years of age with significant baldness
(Norwood-Hamilton grade III or higher; 226 samples), phenotype category 2, men aged 50 or
older lacking baldness (Norwood-Hamilton grade I or II; 179 samples). The remaining subjects
were divided into: phenotype category 3, men below 50 with no signs of baldness (Norwood-
Hamilton grade I or II; 100 samples) and phenotype category 4, men aged 50 years or older with
significant baldness (Norwood-Hamilton grade III or higher; 100 samples). Primary statistical
analyses, including association testing and development of suitable prediction models, used
305 samples from extreme phenotype categories 1 (176 men) and 2 (129 men). This set includ-
ed samples from Poland (73.4%), the Netherlands (12.5%), the United Kingdom (7.2%), Italy
and Spain (6.9%). Such approach identified high-risk MPB alleles. The testing set of 300 inde-
pendent samples was used to evaluate the model accuracy. These additional samples comprised
of subset 1, 50 samples of phenotype category 1; subset 2, 50 samples of category 2; subset 3, 100
samples of category 3 and subset 4, 100 samples of category 4. Initially, only the phenotypic ex-
treme subsets 1 and 2 were used to evaluate predictive accuracy. This initial test set was about
30% of the discovery set with samples from Poland (59%), Denmark (10%), Germany (10%),
the Netherlands (9%), the United Kingdom (6%) and Italy or Spain (6%). The developed pre-
diction models were then further tested by expanding test sets with categories 3 and 4. This
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allowed assessment of the model’s performance in a general population to gauge usefulness
when an unknown sample is examined. Discovery and testing sets were matched by age and de-
gree of baldness. Details of the study sets used for association testing and subsequently for de-
velopment and testing of prediction models are given in S2 and S3 Tables.
Genotyping
A set of 45 SNPs was selected from previous AGA association studies, including all GWAS
analyses [8,9,11,12,14–16,28,29]. An additional five hair morphology-associated SNPs were in-
cluded in order to assess a recent hypothesis claiming a possible association between hair distri-
bution and morphology [16,30]. Details of all selected candidate polymorphisms this study
analyzed are given in S4 Table. DNA from the buccal swabs and whole blood was extracted
using NucleoSpin Tissue extraction kit (Macherey-Nagel GmbH & Co.KG, Germany) [31],
PrepFiler Express BTA DNA Extraction Kit or QIAamp DNAmini kit (Qiagen, Hilden,
Germany). DNA was amplified in four PCR multiplex reactions consisting of 2.5 μL Qiagen
Multiplex PCR mixture, 0.5 μL Q solution, 0.5 μl primer premix and 1.5 μL of 1–10 ng DNA.
Thermocycling conditions were: 95°C for 15 min, 32 cycles of [94°Cx30s, 58°Cx90s, 72°Cx90s]
then 72°C for 10 min. Most samples were genotyped using SNaPshot single base extension
(SBE). PCR products were first purified using Exonuclease I (ExoI) and FastAP Thermosensi-
tive Alkaline Phosphatase (FastAP) (Thermo Fisher Scientific, TFS), then SBE reactions used
1 μl of purified PCR product, 0.5 μl of SNaPshot mix, 0.5 of μl extension primer premix and
DNase free water to 5 μl with 26 cycles of [96°Cx10s, 50°Cx5s, 60°Cx30s]. SBE products were
purified with FastAP (TFS) and analysed with capillary electrophoresis using an ABI 3130xL
Genetic Analyser. Further details are given in S5 Table. Samples from the UK were genotyped
with next-generation sequencing using the KAPA Hyper Prep kit (Kapa Biosystems) according
to manufacturer’s directions. Sequencing was made with the Illumina MiSeq system. SNP
rs6945541 gave amplification problems due to duplication of the chr7 region where it is sited,
necessitating one primer redesign and repeat genotyping. However, old and new primer sets
gave 100% concordance (primer sequences in S5 Table).
Statistical analyses
Population analysis. All variant data was analyzed for concordance with Hardy-Weinberg
expectations using Arlequin v.3.1 (http://cmpg.unibe.ch/software/arlequin3). Haploview ver-
sion 4.2 tested linkage disequilibrium between closely positioned SNPs (www.broadinstitute.
org). Chromosome positions used in the linkage disequilibrium (LD) analysis were retrieved
from GRCh37.p13 genome build (coordinates listed in S4 Table).
Association testing. The 50 SNPs were tested for association with MPB using binary logis-
tic regression analyzed with IBM SPSS statistics v.22 (SPSS Inc., Chicago, IL, USA). The depen-
dent variable was coded dichotomously as ‘1’ for phenotype category 1 and ‘0’ for phenotype
category 2. Independent variables (SNPs) were tested using additive (SNP genotypes coded 0,
1, 2 for the number of minor alleles); dominant (SNP genotypes coded ‘0’ for no minor allele or
‘1’ for at least one minor allele) and recessive (coded ‘0’ for no minor allele or one minor allele
or ‘1’ for two minor alleles) inheritance modes. X-linked SNPs coded minor allele homozygotes
as ‘2’ and major allele homozygotes as ‘0’. Odds ratios, corresponding 95% confidence intervals
(CI) and p-values were estimated for all minor allele classifications. All analyses considered a
P-value at<0.05 as statistically significant and correction for multiple hypothesis testing was
not applied in this study. Minimal OR values detectable with a power of at least 80% were cal-
culated with Power and Sample Size Program (PS Program) v.3.1.2 (http://biostat.mc.
vanderbilt.edu/wiki/Main/PowerSampleSize).
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Genotype risk score. As each tested SNP contributes to a small extent to individual risk of
AGA, the combined effect of five SNPs selected by multivariate association analysis was as-
sessed by estimating the Genotype Risk Score (GRS). GRS was calculated using a weighted risk
alleles counting approach by adding up all weighted risk alleles (according to logistic regression
β parameter) in five selected SNPs [12,32]. The resulting GRS was then divided into quartiles
and the lowest quartile used as a reference to calculate the risk of AGA for the remaining three
quartiles [12]. ORs and their respective p-values for designated quartiles were then assigned.
The same procedure was applied to evaluate the combined effect of eight MPB loci described
by Li et al. in their studied population set [12].
Epistasis testing. Analysis of SNP-SNP interactions was conducted on the discovery data-
set using Multifactor Dimensionality Reduction (MDR v.2.0 beta 8.1, www.epistasis.org) and
binary logistic regression (IBM SPSS statistics v.22) as previously described [31]. The MDR
method identifies specific genotype combinations at ‘high risk’ for a given phenotype and uses
an entropy-based approach to estimate the benefit in information gain from considering inter-
actions between the tested SNPs [33–36]. Standard binary logistic regression was used to study
pair-wise interactions at the multiplicative scale and for the disclosed epistatic effects ORs, re-
spective 95% CIs and P-values were calculated.
Prediction modeling. Two prediction models were developed using logistic regression
(IBM SPSS statistics v.22) applied to data from the discovery set of the 305 samples used for as-
sociation and interaction analyses (S2 Table). The first prediction model included five SNPs se-
lected as most significant using multivariate logistic regression. The second prediction model
assessed twenty SNPs with positive, detectable impact on prediction accuracy. DNA variants
increasing AUC by at least 0.001 were chosen. For this purpose, the ascertained SNPs were
ranked according to their individual significance of association and sequentially tested for im-
pact on prediction accuracy expressed by the area under the ROC curve (AUC). The AUC pa-
rameter indicates overall accuracy of prediction including sensitivity and specificity measured
at different probability thresholds (an AUC value of 0.5 signifies complete lack of prediction
and 1.0 perfect prediction). Those SNPs not showing statistical significance for association
were also evaluated for their impact on prediction following the suggestions in a previous study
[21]. Performance of the developed prediction models was evaluated with an independent test
set by calculating AUC, sensitivity, specificity, positive predictive value (PPV), negative predic-
tive value (NPV), total correct predictions for each phenotype category plus overall number of
correct predictions [20,21,37,38]. Calculations were performed using 50% or 65% probability
thresholds. Prediction results that failed to exceed the 65% probability threshold were consid-
ered inconclusive. The independent test set comprised 300 samples of the four age/phenotype
categories that reflected the full range of MPB grade/age variation, making a general European
male hair distribution ‘profile’ (S3 Table). Individuals from phenotype categories 1 and 4 were
treated as ‘bald’ and coded ‘1’ whereas categories 2 and 3 were ‘non-bald’, coded ‘0’. Therefore,
the ability of the developed prediction models to predict individuals in subsets 1 and 4 as ‘bald’
and subsets 2 and 3 as ‘non-bald’ was tested by their assignment to particular phenotype cate-
gories. The SNP-SNP interactions detected fromMDR were also evaluated for their impact on
prediction. The proportion of overall risk of AGA explained by the developed prediction mod-
els was estimated using the Nagelkerke pseudo-R2 statistic (IBM SPSS statistics v.22).
Results
Population data
Genotype data for 50 SNPs are provided in S6 and S7 Tables, for the discovery and testing sam-
ple sets respectively. The genotyping completion rate exceeded 99% for all markers. Analysis of
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the autosomal data in the full sample of 605 European men showed marginal deviation from
Hardy-Weinberg equilibrium for two SNPs rs6137444 and rs1800547 (P>0.04, S8 Table). De-
tails of LD analyses are shown in S1 Fig. Briefly, three haplotype blocks (r2>0.8) comprising 17
SNPs were found in the Xq12 region and one LD block comprising five SNPs (r2>0.8) was de-
tected on chr20. Three SNPs from the chr17 region revealed the strongest LD (r2>0.9), while
LD was also detected between rs2249817 and rs6461387 on chr7 (r2>0.8) and four SNPs on
chr1 (r2>0.7).
Association testing
From association testing of all 50 SNPs in 305 samples, 29 markers were found to be signifi-
cantly associated with AGA in univariate analyses (S4 Table). Among the SNPs associated with
MPB were 17 SNPs on Xq12, 8 SNPs on chr20, one SNP on chr1 (rs12565727), one SNP on
chr5 (rs929626), one SNP on chr7 (rs756853) and one SNP on chr18 (rs10502861). The highest
statistical significance was detected for rs5919324 positioned upstream of AR on Xq12
(OR = 0.536, 95% CI = 0.390–0.735, P = 1.119x10-4). From SNPs located on 20p11 the highest
statistical significance was obtained for rs1998076 with OR = 0.541, 95% CI = 0.388–0.754
and P = 2.941x10-4. From the remaining chromosomes, high statistical significance was found
for rs929626 (chr5) OR = 0.353, 95% CI = 0.205–0.608, P = 1.75x10-4; rs12565727 (chr1)
OR = 0.478, 95% CI = 0.293–0.780, P = 3.11x10-3; and rs10502861 (chr18) OR = 0.531, 95%
CI = 0.335–0.841, P = 7.0 x10-3. Notably, a higher significance was observed for these three
SNPs when dominant allele categorization was applied. SNP rs756853 (chr7) was also signifi-
cant with dominant allele categorization (OR = 1.760, 95% CI = 1.101–2.812, P = 0.018). The
same association pattern in terms of the associated genes was observed for the entire discovery
set and for a set restricted to Polish samples. Minor differences were observed in terms of asso-
ciation significance of various SNPs within the studied loci (data not shown). Multivariate as-
sociation analysis considering the full 50 SNP set enabled selection of the most important
polymorphisms showing independent effects in AGA (Table 1). The subsequent multivariate
model included the five SNPs: rs5919324 (P = 9.883x10-5, OR = 0.480, 95% CI = 0.332–0.695);
rs1998076 (P = 1.382x10-4, OR = 0.482, 95% CI = 0.331–0.701); rs929626 (P = 1.623x10-3,
OR = 0.557, 95% CI = 0.387–0.801); rs12565727 (P = 2.591x10-3, OR = 0.493, 95% CI = 0.311–
0.781) and rs756853 (P = 0.015, OR = 1.595, 95% CI = 1.094–2.324). Association testing con-
firmed the highest association for the known MPB susceptibility region on Xq12 containing
AR and EDA2R loci. It was estimated that males with the rs5919324-T allele have 2.1 times in-
creased risk to develop MPB compared to those with the C allele. It is notable that a similar in-
crease of MPB risk was found to be associated with rs1998076-C on 20p11 (Table 1). The
remaining three most significant SNPs associated with AGA susceptibility were rs12565727-T
Table 1. Results of multivariate logistic regression analysis for AGA performed on a discovery set consisting of 305 samples.
Multivariate logistic regression analysis
Variables in model Genes Chr Allelic variants MAF OR (95% CI) Risk allele P value of variable in model
rs5919324 up of AR X C/T C (0.17) 0.480 (0.332–0.695) T 9.833x10-5
rs1998076 - 20 C/T T (0.39) 0.482 (0.331–0.701) C 1.382x10-4
rs929626 EBF1 5 C/T C (0.47) 0.557 (0.387–0.801) T 1.623x10-3
rs12565727 TARDBP 1 C/T C (0.18) 0.493 (0.311–0.781) T 2.591x10-3
rs756853 HDAC9 7 C/T C (0.39) 1.595 (1.094–2.324) C 0.015
MAF: Minor allele frequency; OR: Odds ratio for the minor allele; CI: Conﬁdence interval
doi:10.1371/journal.pone.0127852.t001
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(chr1), rs929626-T (chr5) and rs756853-C (chr7) increasing the risk to develop baldness by
factors of 2.0, 1.8 and 1.6 respectively. The combined effect of these five principal MPB predic-
tors (indicated by multivariate logistic regression) was further evaluated by GRS estimation
from division into quartiles. The risk score associated with the genotypes from the highest
quartile vs. the lowest quartile was estimated to equal OR = 3.135 (95% CI = 2.242–4.386,
P = 2.840x10-11), although an increased risk of MPB was detected in each quartile (Table 2).
The mean number of risk alleles in the selected five top SNPs in the highest GRS quartile was
7.97. Analysis of all genotypes in the five SNPs in discovery set samples showed there was a sig-
nificantly higher proportion of men from phenotype category 1 possessing more than seven risk
alleles compared with men from phenotype category 2 (χ2 P = 1x10-8, Fig 1). It is worth
highlighting that the combined effect of eight MPB loci identified by the study of Li et al.
(2012) was actually lower (OR = 2.641).
Prediction modeling
Two prediction models were developed based on genotype data obtained for the discovery set
of 305 individuals from phenotype categories 1 and 2. The first model included the five most as-
sociated SNPs selected by multivariate association analysis. According to the Nagelkerke pseu-
do-R2 statistic, this model explained*22% of the total risk to develop MPB with the overall
Table 2. Genotype risk score associated with the risk of male pattern baldness.
Quartiles of a genotype risk score OR (95% CI) P value
Quartile 1 Reference -
Quartile 2 2.717 (2.037–3.623) 1.079x10-11
Quartile 3 2.865 (2.114–3.891) 1.422x10-11
Quartile 4 3.135 (2.242–4.386) 2.840x10-11
doi:10.1371/journal.pone.0127852.t002
Fig 1. Numbers of risk alleles found in phenotype categories 1 and 2. Distribution of risk alleles in the top
five SNPs selected by multivariate logistic regression for phenotype category 1 (men <50 years with
significant baldness) and men in phenotype category 2 ( 50 years without baldness) of the discovery
set samples.
doi:10.1371/journal.pone.0127852.g001
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significance P = 1.772x10-10. This model was tested using an independent set of 300 males
from all four phenotype categories. Initially, only the two subsets consisting of 50 samples each
from phenotype category 1 and category 2 were used to test accuracy. These initial analyses indi-
cated the simple MPB prediction model has an overall predictive accuracy expressed as
AUC = 0.762. Applying the 50% probability threshold the overall number of correct predic-
tions was 66% (66/100). However, the 65% probability threshold increased correct predictions
to 75.8% (47/62), while 38 samples produced inconclusive results (S9 Table). Testing per-
formed on the 300 sample set (with additional 100 samples each from phenotype category 3 and
category 4), reduced correct predictions to 54.7% and AUC = 0.594. Predictions for this
dataset also remained weak with the 65% probability threshold, with 58.4% correct predictions
(108/185) and 38.33% inconclusive results (S9 Table). This obvious drop of predictive accuracy
was mainly caused by a near-complete lack of prediction success for phenotype category 3. The
number of correct predictions of non-bald phenotype in this group was just 37.3% (S9 Table).
Slightly lower predictive accuracy was also noted for phenotype category 4 (50 years with sig-
nificant baldness), where the level of correct predictions for baldness reached 60.9%. Therefore,
good predictive performance was obtained for categories 1 and 2 (87.1% and 71% correct pre-
dictions respectively using 65% probability threshold, S9 Table). The next stage of extended
variant sets comprised 20 SNPs with positive impact on AUC: six in region Xq12 (rs5919324,
rs1041668, rs6625163, rs6625150, rs962458, rs12007229), five in 20p11 (rs1998076, rs2180439,
rs913063, rs1160312, rs6113491), three chr7 SNPs (rs756853, rs6461387, rs6945541) and sin-
gletons: rs12565727 (chr1); rs7349332 (chr2); rs4679955 (chr3); rs929626 (chr5); rs9668810
(chr12) and rs10502861 (chr18), as summarized in Fig 2A. This enhanced model explained
35% of the total variance of the risk of AGA with an overall significance of P = 5.286x10-7. No-
ticeable improvement of all accuracy parameters was achieved with the enhanced prediction
model (Table 3). For the testing set including only the first two phenotype categories, AUC in-
creased to 0.864. The overall level of correct predictions was higher at 74% (50% probability
threshold) and 88.5% (65% threshold), with 39% inconclusive results. The number of correct
predictions of bald phenotype in phenotype category 1 increased from 66% to 76% compared to
the simple 5-SNP model. An increase in the number of predictions was also noted for non-bald
phenotype in phenotype category 2 from 66% to 72%. Applying the 65% probability threshold,
the level of correct predictions of bald stage reached the comparatively high level of 87.1% (27/
31) in phenotype category 1. Moreover, the level of correct predictions of non-bald category 2
reached 90% (27/30), substantially higher than the simple 5-SNP prediction model (71%). In
similar results to the 5-SNP model, the enhanced prediction model did not work well with the
general population sample of men at all ages and levels of balding. AUC for the testing set re-
flecting the full European population, although slightly better than the simple prediction
model, was still low with an AUC of 0.66. Applying 65% probability threshold very weak pre-
diction accuracy of non-bald phenotype category 3 was found, with 42.4% correct predictions.
Also, 67.7% of correct predictions of bald phenotype category 4 were only slightly better than
the 5-SNP model (Table 3). Finally, based on the results using the 20-SNP prediction model
and 65% probability threshold, we investigated parameters of MPB prediction in the separated
age groups:< 50 years (phenotype categories 1 and 3) and 50 years (phenotype categories 2
and 4). Overall accuracy of MPB prediction in men less than 50, expressed by AUC, was 0.657.
This weak result was caused by very low specificity of prediction (42.4%, 28/66) while sensitivi-
ty was 87.1% (27/31). Values of PPV and NPV were 41.5% and 87.5%, respectively and there
were 34.5% (51/148) inconclusive results. The overall accuracy of MPB prediction in men 50
years was markedly higher (AUC = 0.761). In this age group sensitivity was 67.7% (44/65) and
specificity was relatively high at 90% (27/30). PPV and NPV were 56.3% and 93.6%, respective-
ly (Fig 2B).
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MDR was used to assess the possible effect of epistasis in explaining AGA variance and
whether it improved prediction accuracy. MDR revealed high significance for a 3-factor model
consisting of rs929626 (chr5), rs1998076 (chr20) and rs10502861 (chr18), taking into account
the interaction between rs929626 and rs1998076 (P<0.001). According to the entropy-based
analysis, this interaction has redundant character, (i.e. redundant information from both fac-
tors). SNP rs929626 (chr5) treated independently explains 3.68% of entropy, (i.e. it removes
3.68% of ‘uncertainty’ in AGA determination). SNP rs1998076 (chr20) treated as a single factor
Fig 2. A. Contributions to the AUC value of twenty SNPs from the extendedmodel of MPB prediction. B. AGA prediction parameters for the 20-SNP
model.Rate of correct predictions in two groups of men, aged <50 and50 years, and four distinct phenotype categories using a 65% probability threshold.
doi:10.1371/journal.pone.0127852.g002
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removes 3.31% of uncertainty. The entropy of the interaction between these two SNPs was
-1.63%, suggesting this part of variation in determination of AGA is common for both SNPs
(Fig 3). Importantly, this effect was confirmed by logistic regression (OR = 0.579, 95%
CI = 0.448–0.747, P<0.001). Logistic regression analysis also indicated several additional inter-
action effects of statistical significance in the determination of AGA (data not shown) that sug-
gest several epistatic effects for this trait, but this needs to be examined with a larger sample.
The interaction between rs929626 and rs1998076 that both show independent main effects and
are included in both prediction models, was found to have an ambiguous effect on prediction
accuracy. It increased AUC from 0.864 to 0.870 when samples from phenotype categories 1 and
2 were subjected to testing, but decreased AUC from 0.660 to 0.658 when the entire testing set
was studied. Thus, the interaction was not included in the final 20-SNP prediction model.
Discussion
Male pattern baldness is a type of androgenetic alopecia that affects susceptible individuals and
progresses with age to form a key human externally visible trait. In European populations, the
progressive loss of scalp hair can start at an early stage in adulthood. Rhodes et al. observed
16% of significant hair loss in men aged 18–29 years, increasing to 43–50% before the age of 50
[39].
The polygenic nature of MPB was discovered in early studies [40,41] and confirmed in
GWAS analyses that followed [9,12,14,16]. The role of androgens had also been established as
an important part of the predisposition to MPB and its age-related onset. Therefore, the andro-
genetic pathway is a process certain to contribute to MPB variation [27,42]. The Xq12 region
that includes androgen receptor (AR, OMIM: 313700) continues to show the best-documented
and strongest association with MPB. This region also contains ectodysplasin A2 receptor
(EDA2R, OMIM: 300276), but it is still not fully understood whether one or both genes play a
role in the progression of AGA. Our study confirmed that the AR/EDA2R region forms the
major risk factor for MPB with the highest significance shown by rs5919324 located upstream
of AR. The same SNP was previously shown to have the most significant association with MPB
Table 3. Parameters describing the accuracy of prediction of MPB using 20-SNP logistic regression prediction model.
The enhanced 20-SNP model for male pattern baldness prediction
Type of testing set samples Phenotype categories 1 and 2 Phenotype categories 1, 2, 3 and 4
Type of model 50% probability
threshold
65% probability
threshold
50% probability
threshold
65% probability
threshold
AUC 0.864 0.660
Overall number of correct predictions % 74% (74/100) 88.52% (54/61) 59.06% (176/298) 65.63% (126/192)
Correct predictions of bald phenotype in phenotype
category 1
76% (38/50) 87.10% (27/31) 76% (38/50) 87.10% (27/31)
Correct predictions of non-bald phenotype in
phenotype category 2
72% (36/50) 90% (27/30) 72% (36/50) 90% (27/30)
Correct predictions of non-bald phenotype in
phenotype category 3
- - 48.98% (48/98*) 42.42% (28/66)
Correct predictions of bald phenotype in phenotype
category 4
- - 55.10% (54/98*) 67.69% (44/65)
Inconclusive results (non-prediction rate) - 39% (39/100) - 35.14% (104/296*)
*Four samples from phenotype categories 3 and 4 lacked data in one of the following SNPs: rs1160312, rs6625150, rs4679955 and therefore were
excluded from the analyses.
doi:10.1371/journal.pone.0127852.t003
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in the study of Cobb et al, 2010 [11]. Cobb found the second strongest association with MPB
from the 20p11 region between PAX1 encoding paired box protein 1 and FOXA2 encoding
forkhead box protein A2 [9,14]. From seven SNPs located in this region and included in our
study, the highest significance was recorded for rs1998076, which was previously shown to be
associated with MPB in a German population sample [14]. Richards et al. reported that the risk
of AGA increases substantially (OR = 7.12) in individuals having at least one risk allele at both
the Xq12 and 20p11 loci. They further estimated that these two loci have very high sensitivity
of MPB prediction (98.2%) but very low specificity (6.6%) [9]. Interestingly, different SNPs on
Xq12 have been shown to be most significantly associated in various European populations, in-
dicating a complex genetic architecture for the region [4,8,10,11]. Moreover, the AGA-associat-
ed region on 20p11 contains no recognized genes to date, so it can only be speculated whether
variation in this area has a regulatory function for PAX1 and/or FOXA2 located at each of the
region’s ends [43]. It is also worth emphasizing that in our study six SNPs from Xq12 and five
SNPs from 20p11 were found to have positive influence on prediction accuracy and thus all
were included in the extended 20-SNPs prediction model. Further studies are necessary to ana-
lyze in more detail whether multiple DNA variants may contribute to MPB development in
these two major AGA loci. If this is the case, it will have a strong impact on prediction model-
ing. Allelic heterogeneity is already recognized as an important factor affecting trait prediction
analyses [21,25,37,44].
Beyond Xq12 and 20p11, ten additional loci have been shown to contribute to the overall
risk of developing MPB [12,15,16]. From these, the most significant associations with AGA in
Fig 3. Entropy-based interaction graph fromMDR analysis. Entropy values in the cells of individual SNPs
indicate the main independent effects. Entropy values marked on the lines connecting two SNPs represent
the entropy of interaction. Blue lines indicate a high degree of redundancy, green lines a reduced degree of
redundancy and gold lines represent independence or additivity.
doi:10.1371/journal.pone.0127852.g003
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our study were found for SNPs located on chromosomes 1, 5 and 7. Beyond rs5919324 (Xq12)
and rs1998076 (chr20), three additional SNPs indicated independent effects when assessed
with multivariate regression analysis. First, we found strong association for rs929626 located in
an intron of EBF1 (early B-cell factor 1), with this SNP originally identified in large meta-analy-
sis of European males [16]. Transcription factor EBF-1 encoded by EBF1 is an important regu-
lator of cell differentiation of adipocytes [45]; known to be involved in the regulation of hair
follicle cycling [46]. SNP rs929626 was observed to have a positive impact on prediction in this
study as well as interacting with rs1998076 (chr20). This interaction is novel and further stud-
ies on larger sample sets are necessary to confirm the effect and its biological mechanism. Im-
plementation of the epistatic effect into the prediction model was found to have an ambiguous
effect on accuracy and therefore was not included in the final 20-SNP prediction model. Sec-
ond, rs12565727 close to TARDBP (TAR DNA binding protein) on chr1 gave the next highest
association. This AGA determinant gene was recently identified by a meta-analysis performed
by Li et al, in 2012. TARDBP codes for the 43 kDa transactive response DNA binding protein
(TDP-43) and is involved in regulating gene expression and RNA splicing [47]. Third, the last
SNP selected in our multivariate regression model was rs756853 located in an intron of
HDAC9 (histone deacetylase 9) on chr7. This association was first discovered in a GWAS of
German and Australian subjects [15]. The histone deacetylase 9 protein encoded byHDAC9
belongs to the extensive HDAC superfamily, which plays a critical role in the regulation of
gene expression. HDAC proteins are responsible for deacetylation of histones leading to chro-
matin condensation and consequently to transcriptional repression [48]. Brockschmidt, et al.
suggested thatHDAC9might interact with AR through MEF2C transcription factor modulat-
ing AR transcriptional activity [15]. Of six SNPs previously associated with hair morphology
[30], none revealed independent association with MPB in our study. Only DNA variant
rs7349332 inWNT10A showed a positive effect on prediction accuracy (a marginal AUC in-
crease from 0.862 to 0.864) and was among markers included in the final 20-SNPs prediction
model. This SNP was initially associated with hair morphology [30] and then also associated
with MPB in a study of Heilmann et al. who suggested a possible link between hair curliness
and hair loss [16].
Our results are in agreement with the genetic data obtained for AGA so far, indicating the
involvement of multiple genetic loci with average or small individual effects. The study data in-
dicates individuals carrying seven or more AGA risk alleles, in the five most associated loci, are
significantly more susceptible to MPB. The genotype risk score calculated from the combined
weighted number of risk alleles for these loci shows males with the highest genotype scores
contrast to those with the lowest scores by having a three-fold increased MPB risk. These re-
sults can be compared with genotype risk score analysis made in the meta-analysis of Li et al.
2012 assessing 8 loci in more than 12,000 individuals [12]. Li’s study obtained OR = 5.78 but
the genotype risk score calculated in our sample for the same variants gave a lower OR = 2.64.
This is not unexpected, as the 8 SNPs lack associations with MPB in our samples and the gene
from chr17 was not included in the 20-SNP model. In line with these findings, the regression
model Li developed for the 8 SNPs was less accurate than our models (AUC = 0.742, data not
shown). This could be explained by allelic heterogeneity and/or the small number of samples
in our study. Overall, sample size was the main limitation of our study and this affects detection
of small effect size variants and can prevent confirmation of weak association signals discov-
ered in larger studies. We estimated that our sample size was sufficient to detect true effects
with OR2 with 80% probability for only 18 of 50 tested DNA variants.
In other studies investigating susceptibility loci for AGA, selection of risk alleles/genotypes
involved analysis of the two most contrasted phenotypic groups defined by age and MPB grade
using a 50 year age division. Using these two phenotype groups for initial prediction model
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development, our study obtained an overall correct prediction rate of 66% for 5-SNP analyses
using a 50% probability threshold, rising to 75.8% with the 65% threshold but with a 38% non-
prediction rate for probabilities below the threshold. When extended to a 20-SNP prediction
model, the overall number of correct predictions increased markedly to 88.5% (65% threshold,
39% non-prediction rate) with the 5-SNP AUC = 0.762 rising to AUC = 0.864 for the 20-SNP
model. These results underline the observation that weaker predictors can give an important
contribution to overall prediction accuracy when added to the strongest predictors identified
[21]. Positive predictions reached 87.1% for phenotype category 1 and 90% for phenotype cate-
gory 2 and these results can be considered to represent a high level of predictive performance.
The highest level of correct predictions was recorded for males with Norwood-Hamilton V-VII
grades of baldness (79.1%), whereas this only reached 56% for males with I-II grades of bald-
ness (data not shown). In comparison with established forensic EVC prediction system such as
IrisPlex [37], the predictive accuracy achieved in the two extreme MPB phenotype/age catego-
ries is lower than for blue/brown eye colour (AUC>0.9) and for red hair colour (AUC>0.9).
However, it is similar to that reported for black, blond and brown hair colours (AUC>0.8,
AUC = 0.81 and AUC = 0.82, respectively) and intermediate eye colours (AUC*0.69–0.82)
[21,37,49,50]. Good predictive performance has also been achieved for skin colour with only
1–3% prediction errors but relatively high 19–25% non-prediction rates [51,52]. Additionally,
a recent forensic skin colour predictive test was developed showing successful prediction of
white and black skin phenotype (AUC = 0.999 and AUC = 0.966, respectively) but slightly
lower for intermediate skin phenotype (AUC = 0.803) [53]. It is worth noting that division of
samples into four phenotype/age categories allows more insight into prediction accuracy ob-
served in each of these subsets. The data clearly shows that, in contrast to phenotype categories
1 and 2, men<50 years without baldness of phenotype category 3 give a much lower 42.4% cor-
rect predictions. The mean age in this sample subset was 32 years and it is possible that lower
predictive performance reflects the insufficient time for MPB to develop in many of these sub-
jects. Lower prediction accuracy was also obtained in phenotype category 4 of men50 years
with significant baldness, with 67.7% correct predictions. It can be suggested that MPB is a het-
erogeneous phenotype and early onset and later onset alopecia could have different genetic
backgrounds. This idea is indirectly supported by detailed analysis of AGA phenotypes in Eu-
ropeans and Asians, discussed below. Furthermore, there are some indications that senescent
alopecia has a distinct molecular etiology that increases the complexity of prediction of hair
distribution in males [54,55]. Our study shows that the low specificity of 42.4% restricts MPB
prediction in younger men and this observation is worth further investigation. MPB is a pro-
gressive condition and aging in males is accompanied by an increased incidence and degree of
alopecia [27]. Therefore the differences between age-related scalp hair loss and early onset
MPB will influence the applicability of a forensic hair distribution predictive test. For this rea-
son, the ability to predict the biological age of a sample’s unknown donor will be an important
adjunct to MPB predictive tests in forensic application. Considerable recent progress has been
achieved in human age prediction [22–24,55] and further development of forensic MPB pre-
dictive tests will benefit from parallel studies in DNA-based age estimation. When we investi-
gated two groups of men, aged<50 years and50 years, better prediction parameters were
obtained for men aged50 years with sensitivity of 67.7% and specificity of 90%; meaning that
in this age category the currently available set of genetic predictors provides a reasonable accu-
racy for application in forensic analyses.
Another aspect of MPB that needs detailed study concerns inter-population differences in
AGA prevalence and molecular etiology that could influence the heterogeneity of the AGA
phenotype. It has been suggested that the lowest incidence rate of MPB is observed in Africans
[56]. Furthermore, AGA in Asians shows different characteristics compared to Europeans. In
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general, Japanese men develop MPB approximately 10 years later than European men and
MPB is very rare in Japanese men less than 40 years old [57]. From the two most associated re-
gions, only 20p11 has been shown to be associated with MPB in Asian subjects, while no Xq12
association has been detected [13,58]. Since the AR/EDA2R region contributes the most to the
predictive performance of the SNPs we examined in European men, it is likely the prediction
models developed in this study will not be applicable to analysis of Asian males. This aspect of
the genetic control of AGA needs further investigation and indicates that forensic MPB predic-
tion tests will benefit from tests for the inference of biogeographic ancestry [59]. Overall, the re-
sults obtained in this study clearly indicate MPB prediction in forensic DNA analysis is a viable
option but should be applied with caution due to the variation in predictive accuracy relating
to age and likely further variation from differences amongst populations.
Conclusions
The results obtained from this study provide additional evidence that Xq12, comprising AR/
EDA2R and the region on 20p11 are major determinants of AGA in European populations.
Multiple DNA variants in these two regions have a major positive influence on the perfor-
mance of tests designed to predict male pattern baldness. The three additional genes of EBF1,
TARDBP and HDAC9 showed weaker association with MPB but achieved statistical signifi-
cance. The combination of 20 SNPs from ten known MPB-associated loci enabled the develop-
ment of a test with good predictive performance for male pattern baldness in Europeans aged
50 years and older. Further studies are necessary to explain the causes of low specificity of pre-
diction in males less than 50 years old, but insufficient time to develop MPB phenotypes in this
age group is a plausible explanation. The role of senescent alopecia will also need to be ad-
dressed in future developments of predictive tests. However, the prediction models outlined
here have a direct practical application in forensic analysis, particularly when combined with
DNA tests for age and ancestry.
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